Project Number 5R01AG074447-02 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Phase 1 Clinical Trial of CMS121, a Novel Therapeutic Candidate for Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) r. Multi-target Researcher and Organization Principal Investigator RASCHKE, WILLIAM C Principal Investigator First Name WILLIAM C Principal Investigator Last Name RASCHKE Awardee Organization VIROGENICS, INC. Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-877: Early Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional) FY Overall Cost $2,338,814 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official CLARKE, AKANNI YAO
